title: Uveitis in a patient receiving rifabutin for Crohn's disease.
authors.affiliation: Barts & The London School of Medicine & Dentistry, London, UK.
authors.forename: O
authors.initials: O
authors.lastname: Awotesu
authors.forename: T
authors.initials: T
authors.lastname: Missotten
authors.forename: M C
authors.initials: MC
authors.lastname: Pitcher
authors.forename: W A
authors.initials: WA
authors.lastname: Lynn
authors.forename: S
authors.initials: S
authors.lastname: Lightman
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000904:Antibiotics, Antitubercular / Q000009:adverse effects*; D017291:Clarithromycin / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016927:Mycobacterium avium subsp. paratuberculosis; D010283:Paratuberculosis / Q000517:prevention & control; D017828:Rifabutin / Q000009:adverse effects*; D014392:Tuberculosis, Ocular / Q000517:prevention & control; D014606:Uveitis, Anterior / Q000139:chemically induced*
chemical_list: D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D017828:Rifabutin; D017291:Clarithromycin